Can I Get Suboxone Through Telehealth?

If you're looking into starting Buprenorphine treatment for Opioid Use Disorder, one of the first questions people ask is whether they really need to sit in a waiting room before a provider can prescribe it. The short answer is no — not right now. Because of federal telehealth flexibilities that have been extended repeatedly since the COVID-19 public health emergency, you can be evaluated and started on Suboxone through a telehealth visit, without an in-person exam beforehand. Here's what that actually means, and what to expect from a visit with Acorn TeleMAT.

Is it actually legal to get Suboxone through telehealth?

Yes, and it's worth understanding why, because the rules here have changed a lot in the last few years. Normally, a federal law called the Ryan Haight Act requires a provider to conduct an in-person medical evaluation before prescribing a controlled substance like Buprenorphine (a Schedule III controlled medication) via telehealth. During the COVID-19 public health emergency, the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) suspended that in-person requirement for controlled substance telemedicine prescribing — and rather than letting that flexibility lapse, they have extended it several times since.

The most recent extension was published in the Federal Register on December 31, 2025, and it keeps these flexibilities in place through December 31, 2026. Under it, DEA-registered practitioners can prescribe controlled substances, including Buprenorphine, through telehealth without having conducted an in-person medical evaluation first, as long as the prescription is issued for a legitimate medical purpose by a provider acting in the usual course of professional practice.

It's important to be upfront about one thing: this is a temporary flexibility, not a permanent guarantee written into law. It has been extended multiple times, and federal agencies have signaled they're working on longer-term rules, but as of today it's authorized only through the end of 2026. We'll talk more about what that means for you below.

What a telehealth Suboxone visit involves

Even though the law no longer requires an in-person exam, Acorn TeleMAT still requires a real, live clinical evaluation — just conducted by video instead of in an exam room. A telehealth visit for Suboxone typically includes:

• A real-time, interactive video visit with a licensed provider (audio-only is used only when video genuinely isn't accessible to you)
• A clinical history and assessment to confirm an Opioid Use Disorder diagnosis and understand your situation, including prior treatment, other medications, and any co-occurring conditions
• A conversation about treatment goals and what to expect from Buprenorphine, including possible side effects and how induction (starting the medication) works
• A personalized treatment plan, with a prescription sent electronically to your pharmacy if telehealth treatment is appropriate for you
• Scheduled follow-up visits, also by telehealth, to monitor your progress and adjust your plan as needed

This isn't a rushed, five-minute chat. It's a genuine medical evaluation — the same clinical standard of care you'd expect from an in-person addiction medicine visit, just delivered over a secure video connection.

New patients vs. existing patients

Both new and existing patients can generally be seen through telehealth at Acorn TeleMAT. If this is your first-ever evaluation for Buprenorphine treatment, your provider will still conduct a thorough clinical assessment to make sure Suboxone is appropriate and safe for you — the flexibility removes the in-person requirement, it doesn't lower the clinical bar. If you're an existing patient, follow-up visits and refills can typically be handled entirely through telehealth as well, which is one of the reasons this model works so well for ongoing Opioid Use Disorder treatment.

Because Acorn TeleMAT is licensed to treat patients throughout California, you can be seen from home, work, or anywhere else in the state that offers a private, quiet space for your visit. If you'd rather be seen in person, our office in Tustin, CA is also available.

Is this a loophole, or real medical care?

It's real, regulated medical care — not a workaround. Telehealth Buprenorphine prescribing operates under the same DEA registration requirements, prescribing standards, and clinical judgment that apply to in-person addiction medicine. Providers still have to determine that treatment is medically appropriate for each individual patient, document their evaluation, and follow the same standard of care that governs any controlled substance prescription. Addiction medicine organizations have supported keeping these telehealth pathways available specifically because they expand access to evidence-based Opioid Use Disorder treatment for patients who might otherwise face long waits, transportation barriers, or stigma that keeps them from walking into a clinic.

What happens if the telehealth rule expires?

You may see news headlines about DEA telehealth flexibilities "expiring" every year or so — that's because these extensions have historically been granted for limited periods rather than made permanent, and each deadline gets renewed (or, occasionally, adjusted) close to when it's set to lapse. It's understandably confusing from the outside. Our job is to track these rules closely so you don't have to. If the requirements ever do change, we'll work with existing patients to make sure care continues smoothly, which may include an in-person visit if federal or state rules require one at that time.

This article is for general educational purposes and isn't a substitute for individualized medical advice. Telehealth prescribing rules for controlled substances are governed by federal and state regulations that can change; talk with your Acorn TeleMAT provider about your specific situation and current eligibility.